Ontology highlight
ABSTRACT: Background and purpose
DIPG is among the most devastating brain tumors in children, necessitating the development of novel treatment strategies and advanced imaging markers such as perfusion to adequately monitor clinical trials. This study investigated tumor perfusion and 3D segmented tumor volume as predictive markers for outcome in children with newly diagnosed DIPG.Methods
Imaging data were assessed at baseline, during, and after RT, and every other month thereafter until tumor progression for 35 patients (ages 2-16 years) with newly diagnosed DIPG enrolled in the phase I clinical study, NCT00472017. Patients were treated with conformal RT and vandetanib, a vascular endothelial growth factor receptor 2 inhibitor.Results
Tumor perfusion increased and tumor volume
SUBMITTER: Sedlacik J
PROVIDER: S-EPMC4249730 | biostudies-literature | 2013 Jul
REPOSITORIES: biostudies-literature